Skip to main content
Glama

Metabolights

by io.github.pipeworx-io

Entity Profile

entity_profile
Read-onlyIdempotent

"Tell me about X" / "research Acme" / "brief me on Tesla" / "what does Apple do" / "company profile for Microsoft" / "give me the rundown on NVDA" / "everything you know about $TICKER" — full cross-source profile of a US public company in ONE parallel call. ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view. Fans out across SEC EDGAR, XBRL, USPTO patents, federal contracts (USAspending), FDA-licensed biologics (Purple Book), H-1B hiring (DOL LCA), news and GLEIF, and returns: cik + company_name (+ resolved_from/resolved_to when value was a name); recent_filings (up to 5 with pipeworx://edgar/company/{cik}/filings/{accession} URIs); fundamentals (LATEST 10-K Revenues + NetIncomeLoss + Cash, sorted period_end DESC); patents (USPTO PatentsView API sunset May 2025 — soft-fails until reactivated); federal_contracts (USAspending awards where the company is the recipient); fda_products (FDA-licensed biologics — vaccines, cell/gene therapies — from the Purple Book; a company with only small-molecule/generic drugs will show none here, that is expected, not a failure); hiring (H-1B sponsorship volume + salary range from DOL LCA filings); recent news mentions via GDELT→GNews fallback; LEI via GLEIF. sources_used / sources_failed say which of these actually returned data for THIS company — an empty section is a real "no data", not a bug. Pass a ticker ("AAPL"), zero-padded CIK ("0000320193"), OR a company name ("Moderna") — names now resolve via SEC EDGAR's company-name match; a private company (no CIK/ticker) returns resolved:false with an explicit notes line, not a bare failure. type accepts "company" or "ticker" interchangeably — both take the same value shapes above.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYes"company" or "ticker" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon.
valueYesTicker (e.g., "AAPL"), zero-padded CIK (e.g., "0000320193"), or company name (e.g., "Moderna") — names resolve via SEC EDGAR company-name match.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed3 schema fields changed
    • changedInput schema / properties / type / description
      Previous value: -"Entity type. Only \"company\" supported today; person/place coming soon."New value: +"\"company\" or \"ticker\" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon."
    • changedInput schema / properties / type / enum
      Previous value: -[
-  "company"
-]New value: +[
+  "company",
+  "ticker"
+]
    • changedInput schema / properties / value / description
      Previous value: -"Ticker (e.g., \"AAPL\") or zero-padded CIK (e.g., \"0000320193\"). Names not supported — use resolve_entity first if you only have a name."New value: +"Ticker (e.g., \"AAPL\"), zero-padded CIK (e.g., \"0000320193\"), or company name (e.g., \"Moderna\") — names resolve via SEC EDGAR company-name match."
  2. First observed

TDQS

A4.6/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already indicate readOnly and idempotent behavior, and the description adds substantial context: it fans out across named sources, returns resolved/unresolved states, explains sources_used/sources_failed semantics, clarifies that empty sections mean real 'no data', and notes that a private company returns resolved:false with a notes line rather than a bare failure.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness3/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is dense and informative, and most content earns its place given the lack of an output schema, but it is structured as one long run-on paragraph with semicolon-separated clauses that hurt scannability. It would benefit from bullet points or more sentence breaks to make the rich information easier to consume.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With no output schema, the description compensates by enumerating all return sections, including cik, company_name, recent_filings URIs, fundamentals, sources_used/sources_failed, and LEI. It also handles edge cases like private companies, expected empty FDA sections, and source fallbacks, making the tool's behavior effectively complete for an agent.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Although the schema covers 100% of parameters, the description adds meaningful value by enumerating accepted input forms (ticker, zero-padded CIK, company name), explaining that names resolve via SEC EDGAR, and clarifying that type='company' and type='ticker' are interchangeable. This materially reduces ambiguity beyond the schema descriptions.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states the operation: it produces a full cross-source profile of a US public company in a single parallel call, reinforced with concrete trigger phrases like 'tell me about X' and 'research Acme'. It also differentiates itself from chained single-source SEC/XBRL/news lookups by explicitly directing preference to this tool for holistic views.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description gives explicit when-to-use guidance: prefer this over chaining single-pack lookups when the user asks for a holistic view, with examples of such requests. It lacks a formal when-not-to-use clause or named sibling alternatives, but the context and preference directive are strong.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All Metabolights toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

B3.3/5.0
Disambiguation1/5

The vast majority of tools (e.g., ask_pipeworx, ask_pipeworx_grounded, bet_research, polymarket_arbitrage, etc.) are unrelated to Metabolights and overlap heavily with each other in purpose. Only two tools (get_study and search_studies) are clearly distinct and relevant to the server's stated domain.

Naming Consistency2/5

Tool names are highly inconsistent, mixing snake_case (get_study, search_studies), camelCase (ask_pipeworx), and varied verb styles (e.g., validate_claim vs bet_research). No consistent pattern across the set.

Tool Count1/5

With 28 tools, the server is extremely overpopulated for its stated purpose (Metabolights). Only 2 tools actually pertain to metabolomics study access, while the remaining 26 are general-purpose or unrelated (e.g., bet_research, polymarket_edges), making the count highly inappropriate.

Completeness1/5

The Metabolights domain severely lacks completeness: only search_studies and get_study are provided, with no create, update, delete, or upload functionality. The server fails to cover essential operations for its supposed domain.

Resources